Fifth Third Bancorp
CPRX

Fifth Third Bancorp’s Catalyst Pharmaceutical CPRX Stock Holding History

Fifth Third Bancorp’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Buy
28,368
+27,778
+4,708% +$662K ﹤0.01% 1845
2025
Q4 		$13.8K Buy
590
+19
+3% +$423 ﹤0.01% 2032
2025
Q3 		$11.2K Sell
571
-69
-11% -$1.42K ﹤0.01% 2101
2025
Q2 		$13.9K Sell
640
-10
-2% -$236 ﹤0.01% 1908
2025
Q1 		$15.8K Buy
650
+212
+48% +$4.77K ﹤0.01% 1846
2024
Q4 		$9.14K Buy
438
+10
+2% +$215 ﹤0.01% 2002
2024
Q3 		$8.51K Buy
428
+55
+15% +$1.02K ﹤0.01% 2044
2024
Q2 		$5.78K Buy
373
+53
+17% +$825 ﹤0.01% 2085
2024
Q1 		$5.1K Buy
320
+12
+4% +$181 ﹤0.01% 2051
2023
Q4 		$5.18K Buy
308
+86
+39% +$1.18K ﹤0.01% 2178
2023
Q3 		$2.6K Hold
222
– – ﹤0.01% 2338
2023
Q2 		$2.98K Hold
222
– – ﹤0.01% 2345
2023
Q1 		$3.68K Buy
+222
New +$3.66K ﹤0.01% 2424
2021
Q1 		– Sell
-1,000
Closed -$3K – 2423
2020
Q4 		$3K Hold
1,000
– – ﹤0.01% 2168
2020
Q3 		$3K Buy
+1,000
New +$3.91K ﹤0.01% 1958

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fifth Third Bancorp's CPRX Position: Q1 2026 in Review

Fifth Third Bancorp increased its Catalyst Pharmaceutical (CPRX) stake by 4,708% in Q1 2026, buying an estimated $662K and bringing the position to 28,368 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #1845.

Fifth Third Bancorp first reported a position in CPRX in Q3 2020 and has held it in 15 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Fifth Third Bancorp held 28,368 shares of Catalyst Pharmaceutical worth $702K as of Q1 2026.
  • Fifth Third Bancorp bought 27,778 Catalyst Pharmaceutical shares in Q1 2026, an estimated $662K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1845 holding.
  • Fifth Third Bancorp first reported a position in Catalyst Pharmaceutical in Q3 2020 and has held it in 15 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.